LONDON (ShareCast) - There cannot be many FTSE 250 companies forcasting double-digit growth for this year and the foreseeable future. Yet support services group Serco chief executive Christopher Hyman is confident his company will deliver just that. The group is one of those enviable businesses that is set to thrive as economic conditions deteriorate. Buy, says the Mail on Sunday.
At more than $100 a barrel the oil price is still horrendously expensive. Oxford Catalysts believes it can help. The company produces catalysts that create clean fuels from oil, gas, coal and green energy sources, such as waste. Buy, says the MoS.
RGC Holdings, China and Malaysia-based group that specialises in biometrics and radio-frequency identification microchips, looks undervalued, trading at under four times 2008 forecast earnings. One of the reasons has been by issues surrounding the death of major shareholders Nina Wang, whose estate includes a 27 per cent stake in the company and is subject to court proceedings. Investors should keep that overhang situation in mind and exercise caution, although it is thought unlikely that the stock is likely to flood the market any time soon. On under four times earnings, the shares offer good value in a booming market. Buy, says the Sunday Telegraph.
Investors fed up of waiting for the traditional pharma companies to deliver on their promises could do worse than take a look at Dechra. The group is the UK's third largest veterinary drugs and services company - and you know how much Britons love their pets. Apparently others too are learning to love their furry friends, and last week Dechra posted a healthy increase in profits after January's acquisition of VetXX which expanded its presence in several European markets. Buy, the Sunday Telegraph says.
Please note: Digital Look provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look cannot take any responsibility for information provided by third parties. This is for your general information only as not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.
0.50p ()
